SUBSCRIBE
SUBSCRIBE
News   Drug Development

Momenta Pharmaceuticals, Inc. (Jobs) Sees Longer US Review for Generic Lovenox

June 28, 2007 | 
1 min read
NEW YORK, June 28 (Reuters) - Momenta Pharmaceuticals Inc. said on Thursday a U.S. review of its application to sell a generic version of Sanofi-Aventis' big-selling Lovenox blood-thinner is taking longer than it previously projected.
Clinical research Postmarket research
MORE ON THIS TOPIC
FDA headquarters with a purple psychedelic background.
Psychedelics
Final psychedelics guidance suggests FDA is ‘receptive’ to helping companies succeed
July 14, 2026
 · 
3 min read
 · 
Michael Gibney
Open Door in the room, interior background. Symbol of new way, exit, discovery, new opportunities. Business motivation concept, vector illustration
Huntington’s disease
Exit of Roche’s embattled Huntington’s drug ‘tightens’ case for Wave’s more selective ASO
July 13, 2026
 · 
4 min read
 · 
Heather McKenzie
Insights
From sequence to scale: Gene editing’s new era in biologics manufacturing
July 10, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Man walking through a glowing upward arrow shaped doorway with light streaming in from the sky outside, hope, success, 3d render
Alzheimer’s disease
AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist
July 10, 2026
 · 
6 min read
 · 
Michael Gibney